Table of Content

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations


2 Executive Summary


3 Research Methodology


4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges
4.5 Impact of COVID-19 on the Rosacea Treatment Market


5 Porter’s Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market


6 Global Rosacea Treatment Market by, Type
6.1 Overview
6.2 Erythematotelangiectatic Rosacea
6.3 Ocular Rosacea
6.4 Papulopustular Rosacea
6.5 Phymatous Rosacea


7 Global Rosacea Treatment Market by, Drug Class
7.1 Overview
7.2 Alpha Agonists
7.3 Antibiotics
7.4 Antihypertensive Agents
7.5 Corticosteroids
7.6 Immunosuppressants
7.7 Retinoids
7.8 Other Drug Classes


8 Global Rosacea Treatment Market by, Mode of Administration
8.1 Overview
8.2 Oral
8.3 Topical


9 Global Rosacea Treatment Market by, Distribution Channel
9.1 Overview
9.2 Drug Stores
9.3 E-commerce
9.4 Hospital Pharmacy
9.5 Retail Pharmacy


10 Global Rosacea Treatment Market by, Geography
10.1 Overview
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia
10.4.6 New Zealand
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 UAE
10.6.2 Saudi Arabia
10.6.3 Qatar
10.6.4 Iran
10.6.5 South Africa
10.6.6 Rest of Middle East & Africa


11 Key Developments


12 Company Profiling
12.1 Bayer AG
12.1.1 Business Overview
12.1.2 Product/Service Offering
12.1.3 Financial Overview
12.1.4 SWOT Analysis
12.1.5 Key Activities
12.2 Pfizer, Inc
12.3 Mayne Pharma
12.4 AbbVie Inc (Allergan Plc)
12.5 Aclaris Therapeutics
12.6 Bausch Health Companies, Inc
12.7 Leo Pharma
12.8 Nestl? Skin Health (Galderma S.A)
12.9 Sol-Gel Technologies
12.10 Zydus Group
12.11 Foamix Pharmaceuticals
12.12 Dermira